Kymera Therapeutics, Inc. · NASDAQ:KYMR
Atlas Venture Fund X, L.P.'s stake in Kymera Therapeutics, Inc. fell to 2.90% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 13, 2026
Atlas Venture Fund X, L.P.'s stake in Kymera Therapeutics, Inc. fell to 2.90%, 2,384,685 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G/A).
- Stake
- 2.90%
- Shares
- 2,384,685
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Atlas Venture Fund X, L.P. | 2.90% | 2,384,685 |
| ATLAS VENTURE ASSOCIATES X, L.P. | 2.90% | 2,384,685 |
| Atlas Venture Associates X, LLC | 2.90% | 2,384,685 |
| Atlas Venture Opportunity Fund I, L.P. | 0.60% | 462,856 |
| Atlas Venture Associates Opportunity I, L.P. | 0.60% | 462,856 |
| Atlas Venture Associates Opportunity I, LLC | 0.60% | 462,856 |
Source
Related
- Kymera Therapeutics, Inc.
- Atlas Venture Fund X, L.P.
- Kymera Therapeutics, Inc. shareholders
- Form 4 · Mainolfi Nello · Oct 1, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Sep 8, 2026
- Form 4 · Adams Brian · Sep 4, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Aug 14, 2026
- Form 4 · Rooney Terence · Jul 27, 2026